Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
451
Travere Therapeutics
TVTX
$4.91B
| $36.9M | 0.05% |
2,495,114
-207,700
| -8% | -$3.44M |
2019 Q1
25 quarters
|
|
452
Lucid Motors
LCID
$1.51B
| $36.8M | 0.05% |
1,745,135
+299,398
| +21% | +$7.17M |
2024 Q3
3 quarters
|
|
|
TTAN
453
ServiceTitan Inc
TTAN
$7.04B
| $36.5M | 0.05% |
340,500
+314,100
| +1,190% | +$35.1M |
2025 Q1
1 quarter
|
|
454
Teekay
TK
$1.35B
| $36.3M | 0.05% |
4,396,122
+239,747
| +6% | +$1.86M |
2018 Q1
29 quarters
|
|
455
Riot Platforms
RIOT
$6.32B
| $36.2M | 0.05% |
+3,201,149
| New | +$27.2M |
2025 Q2
0 quarters
|
|
456
International Flavors & Fragrances
IFF
$21.6B
| $35.9M | 0.05% |
487,827
-141,673
| -23% | -$10.7M |
2023 Q4
6 quarters
|
|
|
SEZL
457
Sezzle
SEZL
$3.95B
| $35.8M | 0.05% |
+199,900
| New | +$17.7M |
2025 Q2
0 quarters
|
|
|
AMED
458
DELISTED
Amedisys
AMED
| $35.8M | 0.05% |
364,098
+329,198
| +943% | +$31.1M |
2023 Q4
6 quarters
|
|
|
SWTX
459
DELISTED
SpringWorks Therapeutics
SWTX
| $35.7M | 0.05% |
760,600
+574,700
| +309% | +$25.6M |
2025 Q1
1 quarter
|
|
460
Moelis & Co
MC
$4.17B
| $35.7M | 0.05% |
572,144
+78,780
| +16% | +$4.42M |
2024 Q3
3 quarters
|
|
461
Zeta Global
ZETA
$8.29B
| $35.5M | 0.05% |
2,290,410
-1,206,900
| -35% | -$16M |
2021 Q4
14 quarters
|
|
462
Usana Health Sciences
USNA
$271M
| $35.3M | 0.05% |
1,154,830
+69,566
| +6% | +$1.98M |
2013 Q2
48 quarters
|
|
|
WAY
463
Waystar Holding Corp
WAY
$5.08B
| $35.2M | 0.05% |
860,800
+187,100
| +28% | +$7.21M |
2024 Q3
3 quarters
|
|
464
Wabtec
WAB
$47.4B
| $35.1M | 0.05% |
167,895
+9,695
| +6% | +$1.86M |
2022 Q1
13 quarters
|
|
465
Guardant Health
GH
$22.2B
| $35.1M | 0.05% |
675,200
+58,700
| +10% | +$2.62M |
2024 Q3
3 quarters
|
|
466
Alignment Healthcare
ALHC
$1.81B
| $35M | 0.05% |
2,497,700
+440,200
| +21% | +$7.09M |
2021 Q4
14 quarters
|
|
467
Camden Property Trust
CPT
$11.2B
| $35M | 0.05% |
310,200
+196,902
| +174% | +$22.7M |
2024 Q4
2 quarters
|
|
468
CenterPoint Energy
CNP
$25.3B
| $34.8M | 0.05% |
+947,146
| New | +$35.1M |
2025 Q2
0 quarters
|
|
469
Snap-on
SNA
$18.6B
| $34.7M | 0.05% |
111,600
+39,100
| +54% | +$12.4M |
2021 Q2
16 quarters
|
|
470
MetLife
MET
$62.6B
| $34.7M | 0.05% |
431,700
+248,100
| +135% | +$19.1M |
2025 Q1
1 quarter
|
|
471
Best Buy
BBY
$18.5B
| $34.7M | 0.05% |
517,000
+471,500
| +1,036% | +$32M |
2024 Q1
5 quarters
|
|
472
JPMorgan Income ETF
JPIE
$10.9B
| $34.7M | 0.05% |
748,430
+241,581
| +48% | +$11.1M |
2024 Q3
3 quarters
|
|
473
Duke Energy
DUK
$91.1B
| $34.6M | 0.05% |
293,500
-62,550
| -18% | -$7.38M |
2024 Q3
3 quarters
|
|
|
PPL
474
PPL Corp
PPL
$25.7B
| $34.6M | 0.05% |
1,020,772
-231,602
| -18% | -$8.06M |
2024 Q3
3 quarters
|
|
475
Verizon
VZ
$193B
| $34.6M | 0.05% |
+799,363
| New | +$34.6M |
2025 Q2
0 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.